CEO
ModelMole ltd
Oslo, Norway
Ralf Onken is Co-Founder of ModelMole, where he works on applying agentic AI to transform drug discovery. With experience in strategy, business development, and partnerships, he focuses on bridging advanced technology and real-world healthcare innovation.
Ralf Onken is Co-Founder of ModelMole, a company focused on advancing drug discovery through state-of-the-art artificial intelligence. His work centers on leveraging cutting-edge AI technologies to accelerate the identification and development of novel therapeutics, helping bridge the gap between computational innovation and real-world healthcare impact.
With a background in business development, strategy, and international collaboration, Ralf brings a multidisciplinary approach to innovation. He combines deep interest in emerging technologies with practical experience in building partnerships and scaling ventures across sectors.
At ModelMole, he is actively involved in shaping the company’s strategic direction, fostering collaborations, and translating complex AI-driven insights into actionable outcomes for the life sciences industry.
Ralf is particularly passionate about the convergence of AI, biotechnology, and global innovation ecosystems, and is committed to contributing to initiatives that drive meaningful, scalable solutions to some of the world’s most pressing health challenges.
Expertise
European drug discovery platform
ModelMole enables for faster discovery processes, driven by a European perspective and the next evolution of AI in drug discovery.